Legend Biotech Corporation (NASDAQ:LEGN) Q3 2025 Earnings Call Transcript November 12, 2025
Legend Biotech Corporation misses on earnings expectations. Reported EPS is $-0.42991 EPS, expectations were $-0.13.
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech’s Third Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would like now to turn the conference over to Jessie Yeung, Vice President of...
